Latest News about INCY
Recent news which mentions INCY
Earnings Scheduled For February 8, 2022
February 08, 2022
From Benzinga
12 biotech stocks to consider buying now as prospects for the sector brighten this year
February 06, 2022
From MarketWatch
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
From Benzinga
From Benzinga
1 Top Dividend Stock to Buy Right Now
January 28, 2022
From Motley Fool
Incyte Pulls Parsaclisib US Application For Lymphoma Treatment, Bows Out Solid Tumor Program With Merus
January 26, 2022
From Benzinga
2 Beaten-Down Cathie Wood Growth Stocks to Buy and Hold For 10 Years
January 25, 2022
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2022
January 18, 2022
From Benzinga
This Biotech Is Working With Pfizer, Merck KGaA, Roche, and Other Leaders To Develop a Better Standard of Care for Breast Cancer
January 13, 2022
From Benzinga
Cramer Shares His Thoughts On Incyte, Corning And More
December 22, 2021
From Benzinga
4 Stocks Insiders Are Buying
December 20, 2021
From Benzinga
Incyte's Topical JAK Inhibitor Under Priority FDA Review For Depigmented Skin Disorder
December 15, 2021
Tickers
INCY
From Benzinga
Watch These 12 Nasdaq Stocks in 2022
December 13, 2021
From Motley Fool
Lucid and Rivian Are Soaring Again. Which EV Stock Is The Better Buy?
December 13, 2021
From Motley Fool
From Benzinga
7 CEOs That Ought to Follow Jack Dorsey Out the Door
December 10, 2021
From InvestorPlace
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
From Benzinga
7 Stocks 'On Sale' This Holiday Season
November 26, 2021
From Benzinga
Is This Pharma Stock a Buy?
November 22, 2021
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021
November 19, 2021
From Benzinga
From Benzinga
These Clinical Results Are Good News for AstraZeneca
November 06, 2021
From Motley Fool
Incyte Corporation (INCY) Q3 2021 Earnings Call Transcript
November 02, 2021
Tickers
INCY
From Motley Fool
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
November 02, 2021
From Benzinga
From Benzinga
Incyte's Parsaclisib Application Under FDA Review For 3 Types Of Non-Hodgkin Lymphomas
November 01, 2021
Tickers
INCY
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
|
|
|